FLDM Shares Outstanding History
Below is a table of the FLDM shares outstanding history going back to 2/10/2011:

Date FLDM Shares Outstanding
2/10/201118.59M
3/31/201119.97M
7/25/201119.99M
10/31/201120.24M
4/30/201220.51M
7/31/201220.65M
10/31/201224.99M
2/28/201325.27M
4/30/201325.42M
7/31/201325.50M
10/31/201325.61M
2/28/201427.87M
4/30/201428.06M
7/25/201428.17M
9/10/201428.21M
10/31/201428.25M
2/10/201528.37M
3/31/201528.72M
4/30/201528.78M
7/31/201528.71M
10/30/201528.79M
2/10/201628.84M
3/31/201628.90M
4/30/201628.90M
7/29/201629.04M
10/28/201629.12M
2/10/201729.21M
3/31/201729.29M
4/28/201729.30M
7/28/201729.41M
10/27/201738.65M
2/9/201838.81M
4/30/201838.92M
7/31/201839.16M
10/31/201839.32M
3/13/201968.99M
4/30/201969.02M
7/31/201969.40M
12/31/201943.15M
10/31/201969.56M
1/31/202070.45M
4/13/202070.71M
4/30/202070.71M
7/31/202071.32M
10/30/202074.12M
1/31/202174.55M
4/30/202174.96M
7/31/202176.17M

Also see: FLDM Market Cap History
FLDM YTD Return
FLDM Historical Shares Outstanding:
+14.41% CAGR
FLDM Historical Shares Outstanding: +14.41% CAGR

Mouse over chart for data details
2/10/2011 ...7/31/2021
Fluidigm creates, manufactures, and markets a range of products and services, including instruments, consumables, reagents and software that are used by researchers and clinical labs worldwide. Co. markets technologies and life science tools, including preparatory and analytical instruments for Mass Cytometry, polymerase chain reaction, Library Preparation, Single Cell Genomics, and consumables, including integrated fluidic circuits, assays, and reagents. Co.'s product offerings include: Mass Cytometry, Microfluidics and Single Cell Microfluidics. We show 48 historical shares outstanding datapoints in our coverage of FLDM's shares outstanding history.

Understanding the changing numbers of FLDM shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like FLDM versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching FLDM by allowing them to research FLDM shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree FLDM Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Fluidigm (FLDM) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

FLGT Shares Outstanding History
FLKS Shares Outstanding History
FLXN Shares Outstanding History
FMI Shares Outstanding History
FMTX Shares Outstanding History
FNCH Shares Outstanding History
FOLD Shares Outstanding History
FONR Shares Outstanding History
FPRX Shares Outstanding History
FREQ Shares Outstanding History
More Healthcare companies »

 

FLDM Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.